^
    2d
    OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps (clinicaltrials.gov)
    P3, N=72, Active, not recruiting, Optinose US Inc. | Recruiting --> Active, not recruiting | Trial completion date: Mar 2026 --> Jun 2026
    Enrollment closed • Trial completion date
    3d
    Throat pack: Soaked Pharyngeal Packing Agents in Septoplasty (clinicaltrials.gov)
    P3, N=65, Completed, Assiut University | Recruiting --> Completed
    Trial completion
    |
    dexamethasone
    3d
    Sphenopalatine Ganglion Block as Adjuvant to General Anesthesia Regarding the Quality of Surgical Field in Trans-Sphenoidal Endoscopic Hypophysectomy (clinicaltrials.gov)
    P=N/A, N=70, Recruiting, Cairo University
    New trial
    |
    dexamethasone
    3d
    TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients (clinicaltrials.gov)
    P3, N=540, Recruiting, University of Sydney | Not yet recruiting --> Recruiting
    Enrollment open
    |
    prednisone • methylprednisolone sodium succinate
    3d
    Breztri rPMS: BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA (clinicaltrials.gov)
    P=N/A, N=600, Not yet recruiting, AstraZeneca
    New trial
    3d
    Intra-articular Injection for the Relief of Temporomandibular Joint Pain (clinicaltrials.gov)
    P=N/A, N=64, Completed, Cairo University
    New trial
    4d
    Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? (clinicaltrials.gov)
    P1, N=84, Recruiting, Texas Tech University Health Sciences Center, El Paso | Trial completion date: Jan 2026 --> Jan 2028 | Trial primary completion date: Dec 2025 --> Dec 2027
    Trial completion date • Trial primary completion date
    4d
    A Study Comparing Sub-Tenon Steroid Injection Versus Eye Drops for Reducing Postoperative Inflammation After Cataract Surgery (clinicaltrials.gov)
    P=N/A, N=72, Completed, Damascus University
    New trial
    5d
    DIAMOND-1: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) (clinicaltrials.gov)
    P2/3, N=552, Completed, Oculis | Active, not recruiting --> Completed
    Trial completion
    5d
    Ventilation and Perfusion in Asthmatics (clinicaltrials.gov)
    P4, N=40, Recruiting, University of Miami | Not yet recruiting --> Recruiting
    Enrollment open
    5d
    EXO-DEX-SNHL: A Randomized Trial of Intratympanic Drug Delivery: Evaluating the Efficacy and Safety of Dexamethasone-Loaded Exosomes Versus Standard Therapy in Acute Sensorineural Hearing Loss. (clinicaltrials.gov)
    P=N/A, N=30, Recruiting, Kafrelsheikh University
    New trial
    |
    dexamethasone
    5d
    Chrysophanol ameliorates ferroptosis in acute kidney injury by promoting SIRT3-mediated NRF2 deacetylation. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
    To evaluate its prophylactic potential, WT mice were pretreated with CHR (20 and 40 mg/kg, i.g.) for three consecutive days prior to a single LPS injection (15 mg/kg, i.p.), while dexamethasone (2.5 mg/kg, i.p.) served as a positive control...CHR protects against LPS-induced AKI by inhibiting ferroptosis. This prophylactic process is linked to SIRT3-mediated deacetylation of NRF2, highlighting the potential of CHR as a preventive strategy for sepsis-induced renal injury.
    Journal
    |
    IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • GPX4 (Glutathione Peroxidase 4) • SIRT3 (Sirtuin 3) • IL1B (Interleukin 1, beta)
    |
    dexamethasone